Astec LifeSciences Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 1,192.803 million compared to INR 1,287.645 million a year ago. Net income was INR 70.579 million compared to INR 121.639 million a year ago. Basic earnings per share from continuing operations was INR 3.61 compared to INR 6.22 a year ago. Diluted earnings per share from continuing operations was INR 3.6 compared to INR 6.21 a year ago. For the nine months, total revenue was INR 3,893.236 million compared to INR 3,487.276 million a year ago. Net income was INR 410.893 million compared to INR 163.35 million a year ago. Basic earnings per share from continuing operations was INR 21 compared to INR 8.35 a year ago. Diluted earnings per share from continuing operations was INR 20.97 compared to INR 8.35 a year ago.